1. Wang, Yumeng, Wang, Congwen, Qiu, Junjun, Li, Guiling, Hua, Keqin. . Targeting CD96 overcomes PD-1 blockade resistance by enhancing CD8+ TIL function in cervical cancer. In Journal for immunotherapy of cancer, 10, . doi:10.1136/jitc-2021-003667. https://pubmed.ncbi.nlm.nih.gov/35288463/
2. Li, Jiang, Xia, Qidong, Di, Can, Liu, Xinwei, Zhao, Qiyi. 2022. Tumor Cell-Intrinsic CD96 Mediates Chemoresistance and Cancer Stemness by Regulating Mitochondrial Fatty Acid β-Oxidation. In Advanced science (Weinheim, Baden-Wurttemberg, Germany), 10, e2202956. doi:10.1002/advs.202202956. https://pubmed.ncbi.nlm.nih.gov/36581470/
3. Georgiev, Hristo, Ravens, Inga, Papadogianni, Georgia, Bernhardt, Günter. 2018. Coming of Age: CD96 Emerges as Modulator of Immune Responses. In Frontiers in immunology, 9, 1072. doi:10.3389/fimmu.2018.01072. https://pubmed.ncbi.nlm.nih.gov/29868026/
4. Ye, Wenrui, Luo, Cong, Liu, Fangkun, Liu, Zhixiong, Chen, Fenghua. 2021. CD96 Correlates With Immune Infiltration and Impacts Patient Prognosis: A Pan-Cancer Analysis. In Frontiers in oncology, 11, 634617. doi:10.3389/fonc.2021.634617. https://pubmed.ncbi.nlm.nih.gov/33680972/
5. Trumet, Leah, Weber, Manuel, Hahn, Alina, Kesting, Marco, Ries, Jutta. 2023. The Immune Checkpoint Receptor CD96: A Local and Systemic Immune Modulator in Oral Cancer? In Cancers, 15, . doi:10.3390/cancers15072126. https://pubmed.ncbi.nlm.nih.gov/37046787/